Aquatic Capital Management LLC Vir Biotechnology, Inc. Transaction History

Aquatic Capital Management LLC

  • $3.57 Billion
  • Q4 2024

Shares

6 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 14, 2024
BUY
$7.63 - $12.66 $32,809 - $54,438
4,300 Added 330.77%
5,600 $49,000
Q1 2024

May 15, 2024
SELL
$8.6 - $11.9 $15,480 - $21,420
-1,800 Reduced 58.06%
1,300 $13,000
Q4 2023

Feb 14, 2024
BUY
$7.76 - $10.29 $24,056 - $31,898
3,100 New
3,100 $31,000
Q3 2022

Nov 14, 2022
BUY
$18.26 - $31.1 $339,636 - $578,460
18,600 New
18,600 $359,000
Q2 2022

Aug 15, 2022
SELL
$19.08 - $26.7 $22,895 - $32,040
-1,200 Closed
0 $0
Q1 2022

May 16, 2022
BUY
$21.19 - $40.01 $25,428 - $48,012
1,200 New
1,200 $31,000

Others Institutions Holding VIR

# of Institutions
233
Shares Held
90.1M
Call Options Held
1.28M
Put Options Held
235K
View Full List

About Vir Biotechnology, Inc.

VIR Quotes by TradingView
  • Ticker VIR
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 132,638,000
  • Market Cap $730M
  • Description
  • Vir Biotechnology, Inc., a commercial-stage immunology company, develops therapeutic products to treat and prevent serious infectious diseases. It develops Sotrovimab (VIR-7832), a SARS-CoV-2-neutralizing mAbs to treat and prevent COVID-19 infection under the Xevudy brand; VIR-2218 and VIR-3434 for the treatment of hepatitis B virus; VIR-2482 fo...
More about VIR
Track This Portfolio

Track Aquatic Capital Management LLC Portfolio

Follow Aquatic Capital Management LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Aquatic Capital Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Aquatic Capital Management LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email